PSIWM
ATRS

Paradigm Strategies in Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

Paradigm Strategies in Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed – – 254
2021
Q2 		$0 Hold
100
– – ﹤0.01% 276
2021
Q1 		$0 Buy
+100
New +$433 ﹤0.01% 231

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Paradigm Strategies in Wealth Management's ATRS Position: Q3 2021 in Review

Paradigm Strategies in Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q3 2021, closing a stake of 100 shares.

Paradigm Strategies in Wealth Management first reported a position in ATRS in Q1 2021 and held it in 2 quarters. The position peaked at $0 in Q2 2021. 170 funds tracked by Wall St. Rank hold ATRS as of Q3 2021.

  • Paradigm Strategies in Wealth Management reported no remaining Antares Pharma, Inc. position as of Q3 2021 after selling out during the quarter.
  • Paradigm Strategies in Wealth Management sold 100 Antares Pharma, Inc. shares in Q3 2021.
  • Paradigm Strategies in Wealth Management first reported a position in Antares Pharma, Inc. in Q1 2021 and held it in 2 quarters.
  • Paradigm Strategies in Wealth Management's Antares Pharma, Inc. position peaked at $0 in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q3 2021.

Based on Paradigm Strategies in Wealth Management's 13F filing for Q3 2021, filed 15 Oct 2021.